Thursday, May 23, 2013 12:48pm EDT
BMRN - Biomarin Pharmaceutical Inc - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bate Kenneth | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Meier Richard A | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 15,600 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Spiegelman Daniel K | EVP, CFO | 13,200 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 8,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 8,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 2,200 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 12,000 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Young William D | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Lewis Alan | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Lewis Alan | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Lawlis V Bryan | Director | 3,400 | Grant at $0.00 | $0 | |
MMay 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 22,000 | Option exercise at $36.33 | $799,198 | |
MMay 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Sale at $67.90 | $814,784 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 37,800 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Heron Elaine J | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Grey Michael G | Director | 3,400 | Grant at $0.00 | $0 | |
May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Lapalme Pierre | Director | 3,400 | Grant at $0.00 | $0 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Option exercise at $12.99 | $194,850 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Sale at $70.17 | $1,052,492 | |
MMay 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 4,947 | Sale at $70.35 | $348,045 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 3,500 | Option exercise at $21.51 | $75,285 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 20,000 | Option exercise at $21.51 | $430,200 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 20,000 | Sale at $70.34 | $1,406,800 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Option exercise at $21.51 | $430,200 | |
May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Sale at $70.00 | $1,400,000 | |
MMay 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 25,000 | Option exercise at $12.99 | $324,750 | |
MMay 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 25,000 | Sale at $70.94 | $1,773,551 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 2,258 | Option payment at $67.68 | $152,821 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 817 | Option payment at $67.68 | $55,295 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 3,001 | Option payment at $67.68 | $203,108 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 752 | Option payment at $67.68 | $50,895 | |
May 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 1,248 | Sale at $69.26 | $86,431 | |
MMay 10 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,800 | Sale at $68.77 | $1,086,601 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,873 | Option payment at $67.68 | $600,525 | |
MMay 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 14,128 | Gift at $0.00 | $0 | |
MMay 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $12.99 | $103,920 | |
May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 1,096 | Option payment at $67.68 | $74,177 | |
May 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 2,590 | Sale at $69.29 | $179,452 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 479 | Option payment at $65.32 | $31,288 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 1,664 | Option payment at $65.32 | $108,692 | |
MMay 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 1,610 | Gift at $0.00 | $0 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 2,088 | Option payment at $65.32 | $136,388 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 489 | Option payment at $65.32 | $31,941 | |
May 9 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 811 | Sale at $66.00 | $53,528 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 916 | Grant at $22.20 | $20,340 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 3,131 | Option payment at $65.32 | $204,517 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 595 | Grant at $27.91 | $16,603 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 1,305 | Option payment at $65.32 | $85,243 | |
May 7 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $12.99 | $38,970 | |
MMay 7 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $65.87 | $263,492 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,479 | Option payment at $65.32 | $357,888 | |
May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Gift at $0.00 | $0 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 805 | Grant at $23.20 | $18,680 | |
May 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Option exercise at $14.39 | $287,800 | |
May 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Sale at $67.00 | $1,340,000 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 858 | Grant at $23.20 | $19,910 | |
MMay 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 5,854 | Option exercise at $16.31 | $95,459 | |
May 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 5,854 | Sale at $67.19 | $393,327 | |
MMay 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $12.99 | $103,920 | |
MMay 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Sale at $67.24 | $537,950 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 581 | Grant at $23.20 | $13,482 | |
MMay 2 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 12,374 | Option exercise at $18.71 | $231,462 | |
MMay 2 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 16,831 | Sale at $66.17 | $1,113,649 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 797 | Grant at $23.20 | $18,490 | |
May 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 797 | Sale at $64.52 | $51,420 | |
May 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Spiegelman Daniel K | EVP, CFO | 28,000 | Option exercise at $39.06 | $1,093,680 | |
May 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Spiegelman Daniel K | EVP, CFO | 28,000 | Sale at $64.42 | $1,803,897 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 916 | Grant at $23.20 | $21,256 | |
MApr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $64.99 | $194,982 | |
May 2 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $12.99 | $25,980 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 20,000 | Option exercise at $11.05 | $221,000 | |
Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 20,000 | Sale at $63.29 | $1,265,800 | |
MApr 22 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 3,102 | Option exercise at $23.34 | $72,390 | |
Apr 22 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 3,102 | Sale at $65.57 | $203,413 | |
Apr 19 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 5,000 | Option exercise at $21.51 | $107,550 | |
Apr 19 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 5,000 | Sale at $65.00 | $325,000 | |
Apr 10 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Option exercise at $14.39 | $287,800 | |
Apr 10 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Sale at $64.00 | $1,280,000 | |
Mar 26 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Option exercise at $12.99 | $155,880 | |
Mar 26 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Sale at $60.68 | $728,147 | |
MMar 22 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 3,103 | Option exercise at $23.33 | $72,405 | |
Mar 22 2013 | BMRN | Biomarin Pharmaceutical Inc | Wood Mark | VP, HR | 3,103 | Sale at $60.21 | $186,821 | |
Mar 18 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Option exercise at $14.39 | $287,800 | |
Mar 18 2013 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 20,000 | Sale at $61.02 | $1,220,360 | |
Mar 10 2010 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 163,888 | Option exercise at $22.00 | $3,605,536 | |
Mar 10 2010 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 163,888 | Sale at $22.52 | $3,691,020 | |
MMay 4 2010 | BMRN | Biomarin Pharmaceutical Inc | Baffi Robert | EVP, Technical Operations | 16,476 | Gift at $0.00 | $0 | |
Mar 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Grey Michael G | Director | 15,000 | Option exercise at $14.39 | $215,850 | |
Mar 6 2013 | BMRN | Biomarin Pharmaceutical Inc | Grey Michael G | Director | 15,000 | Sale at $60.61 | $909,135 | |
Mar 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 4,000 | Option exercise at $17.86 | $71,440 | |
Mar 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 4,000 | Sale at $60.18 | $240,724 | |
Mar 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 4,000 | Option exercise at $21.51 | $86,040 | |
Mar 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 4,000 | Sale at $60.00 | $240,000 | |
MFeb 28 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 10,000 | Option exercise at $12.99 | $129,900 | |
MFeb 28 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 11,000 | Sale at $59.01 | $649,140 | |
MMar 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 5,023 | Option exercise at $18.21 | $91,464 | |
MMar 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Mueller Brian | VP, Corporate Controller | 7,038 | Sale at $59.76 | $420,577 | |
Mar 1 2013 | BMRN | Biomarin Pharmaceutical Inc | Fuchs Henry J | EVP, Chief Medical Officer | 1,908 | Option payment at $59.61 | $113,736 | |
MFeb 27 2013 | BMRN | Biomarin Pharmaceutical Inc | Davis George Eric | SVP, General Counsel | 8,000 | Option exercise at $15.74 | $125,884 |
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance